Clinical trial

Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer

NCT07189598

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-03-02

PhaseNA

Study timeline

Study start (actual)2026-03-02Date precision: day

Registry last updated2026-04-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

High Risk Prostate Cancerunresolved

Interventions

Adaptive Stereostatic Body RadioTherapy (SBRT) including both Whole Pelvic RadioTherapy (WPRT) and dose-escalation on the Dominant Intraprostatic Lesion (DIL)PROCEDURE

conventional or a moderately hypofractionatedPROCEDURE

Sponsors & collaborators

Center Eugene Marquislead sponsor

Mapped research locations

RennesFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07189598 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.